SAT0118 Calprotectin stratifies disease activity better than acute phase reactants in rheumatoid arthritis patients receiving TNF inhibitors

Background Calprotectin is a major S100 leucocyte protein, associated with disease activity in rheumatoid arthritis (RA) patients. Calprotectin is a potentially biomarker more sensitive of disease activity than conventional acute-phase reactans.

Detalles Bibliográficos
Autores Principales: Inciarte-Mundo, J., Hernández, M., Ruiz-Esquide, V., Ramírez, J., Cuervo, A., Amaya, J., Pascal, M., Yagüe, J., Cañete, J., Sanmarti, R.
Formato: Objeto de conferencia (Conference Object)
Lenguaje:Inglés (English)
Publicado: BMJ Publishing Group 2015
Materias:
Acceso en línea:https://repository.urosario.edu.co/handle/10336/26451
https://doi.org/10.1136/annrheumdis-2015-eular.3394